Ashington Innovation PLC

Equities

ASHI

GB00BNM4K334

Investment Holding Companies

Market Closed - London S.E. 11:35:22 2024-05-28 am EDT 5-day change 1st Jan Change
1.25 GBX +4.17% Intraday chart for Ashington Innovation PLC +38.89% -54.55%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
MetalNRG's legal settlement; Impellam confirms payout AN
Ashington Innovation Ends Merger Talks with Cell Therapy MT
Ashington Innovation to Seek Acquisition Opportunities CI
Ashington Innovation plc Announces Board Changes CI
Ashington Innovation plc Appoints Grant Duthie as Non-Executive Director CI
Literacy Capital nets profit on Butternut Box sale AN
Ashington Innovation Continues Talks for Potential Purchase of Cell Therapy, Calon Cardio-Technology MT
Ashington Innovation inks deal to buy Calon shares for GBP39 million AN
Ashington Innovation to Acquire British Medical Device Company Calon Cardio-Technology MT
Ashington Innovation PLC entered a non-binding heads of terms agreement to acquire Calon Cardio-Technology Limited for £39 million. CI
Ashington to list on Frankfurt Stock Exchange after LSE suspension AN
Ashington Innovation Receives Approval for Frankfurt Listing MT
Ashington Innovation agrees reverse takeover of Cell Therapy AN
Ashington Innovation to Buy UK Regenerative Medicine Company for GBP135 Million MT
Cell Therapy Limited entered into a non binding letter of agreement to acquire Ashington Innovation in a reverse merger transaction PLC for approximately £140 million. CI
Ashington Innovation PLC Announces Board Changes CI
Ashington Innovation PLC Announces A Change to Its Accounting Reference Date and Financial Year End from July 31 to December 31 CI
Chart Ashington Innovation PLC
More charts
Ashington Innovation PLC is a United Kingdom-based special purpose acquisition company (SPAC). The Company is formed for the purpose of acquiring a company or business in the technology sector that it would develop and grow. The Company's objective is to generate an attractive rate of return for shareholders, predominantly through capital appreciation, by taking advantage of opportunities to invest in the technology sector (in particular, the fintech and deep tech sectors) and operating the companies or businesses that it acquires. The Company has no business operations and does not generate any revenue.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. ASHI Stock
  4. News Ashington Innovation PLC
  5. Ashington Innovation Ends Merger Talks with Cell Therapy